# ABEONA THERAPEUTICS INC. (ABEO) MD&A by fiscal year

Verbatim Item 7 Management's Discussion and Analysis sections from ABEONA THERAPEUTICS INC.'s 10-K filings, one page per fiscal year. Extracted from SEC filings with the same bounded parser for every year. Filer text, not grepcent analysis or investment advice.

- [FY 2025 MD&A](/company/ABEO/mda/fy2025/): filed 2026-03-17; accession 0001493152-26-010413 (https://www.sec.gov/Archives/edgar/data/318306/000149315226010413/form10-k.htm); latest 10-K
- [FY 2024 MD&A](/company/ABEO/mda/fy2024/): filed 2025-03-20; accession 0001493152-25-010978 (https://www.sec.gov/Archives/edgar/data/318306/000149315225010978/form10-k.htm)
- [FY 2023 MD&A](/company/ABEO/mda/fy2023/): filed 2024-03-18; accession 0001493152-24-010190 (https://www.sec.gov/Archives/edgar/data/318306/000149315224010190/form10-k.htm)
- [FY 2022 MD&A](/company/ABEO/mda/fy2022/): filed 2023-03-29; accession 0001493152-23-009381 (https://www.sec.gov/Archives/edgar/data/318306/000149315223009381/form10-k.htm)
- [FY 2021 MD&A](/company/ABEO/mda/fy2021/): filed 2022-03-31; accession 0001493152-22-008259 (https://www.sec.gov/Archives/edgar/data/318306/000149315222008259/form10-k.htm)

Back to /company/ABEO/